Media Inquiries

The ADDF's science team includes experts in Alzheimer's disease and related dementias, neuroscience, geriatric medicine, drug discovery, and dementia prevention. They are available for comment on breaking news stories, research trends, and other topics.

To connect with an expert on staff, please contact Krishna Knabe, Director of Communications, at 212.901.7997.

Media Releases

October 27, 2016

ADDF Launches Expanded Brain Health and Dementia Prevention Website

September 29, 2016

New Clinical Trial Will Test Cancer Drug as Alzheimer's Treatment

September 27, 2016

Experimental Imaging Agent Reveals Concussion-Linked Brain Disease in Living Brain

September 22, 2016

Vivreon Biosciences Awarded Grant to Advance Drug Program Targeting Neuroinflammation

September 21, 2016

$1.7 Million Grant Supports Promising Drug That Targets Cannabinoid Receptor